This Article Full Text Full Text (PDF) Data Supplement All Versions of this Article: 23/12/2172    most recent 01.ATV.0000100404.05459.39v1 Alert me when this article is cited Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Request Permissions Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Sarjeant, J. M. Articles by Rabinovitch, M. Search for Related Content PubMed PubMed Citation Articles by Sarjeant, J. M. Articles by Rabinovitch, M. Pubmed/NCBI databases Gene GEO Profiles HomoloGene UniGene Substance via MeSH Related Collections Lipid and lipoprotein metabolism Mechanism of atherosclerosis/growth factors Cell biology/structural biology Gene regulation Growth factors/cytokines Smooth muscle proliferation and differentiation

(Arteriosclerosis, Thrombosis, and Vascular Biology. 2003;23:2172.)
© 2003 American Heart Association, Inc.

Vascular Biology

Apolipoprotein D Inhibits Platelet-Derived Growth Factor-BB–Induced Vascular Smooth Muscle Cell Proliferated by Preventing Translocation of Phosphorylated Extracellular Signal Regulated Kinase 1/2 to the Nucleus

Jennifer M. Sarjeant; Allan Lawrie; Caroline Kinnear; Shmuel Yablonsky; Wesley Leung; Hamid Massaeli; Wendy Prichett; John P. Veinot; Eric Rassart; Marlene Rabinovitch

From the Cardiovascular Research Program (J.M.S., C.K., S.Y., W.L., H.M., M.R.), The Hospital for Sick Children, and the Departments of Pediatrics, Laboratory Medicine, and Pathobiology and Medicine, University of Toronto; Ottawa Health Research Institute (W.P.), Ottawa Hospital; Division of Anatomical Pathology (J.R.), Ottawa Hospital and Department of Pathology and Laboratory Medicine, University of Ottawa; and Département des Sciences Biologiques (E.R.), Université du Quebec à Montréal, Canada. A.L. and M.R. are presently at the Department of Pediatrics, Stanford University School of Medicine, Stanford, Calif.

Correspondence to Dr Marlene Rabinovitch, Stanford University School of Medicine, CCSR Room 2245B, 269 Campus Dr, Stanford, CA 93405-5162. E-mail marlener{at}stanford.edu

Objective— Elevated apolipoprotein D (apoD) levels are associated with reduced proliferation of cancer cells. We therefore investigated whether apoD, which occurs free or associated with HDL, suppresses vascular smooth muscle cell (VSMC) proliferation, which is related to the pathobiology of disease.

Methods and Results— Intense immunoreactivity for apoD was observed in human atherosclerotic plaque but not in normal coronary artery. However, an increase in apoD mRNA was seen in quiescent relative to proliferating fetal lamb aortic VSMCs, and in the rat aortic VSMC line (A10), we demonstrated uptake of apoD from serum. Stable transfection of apoD in A10 cells in the absence of serum did not influence VSMC proliferation assessed by [³H]-thymidine incorporation. ApoD, administered at a dose of 100 ng/mL, completely inhibited basal as well as platelet-derived growth factor (PDGF)-BB–induced VSMC proliferation (P<0.01) but had no effect on fibroblast growth factor–induced VSMC proliferation. ApoD did not suppress PDGF-BB or fibroblast growth factor-2–induced phosphorylation of extracellular signal regulated kinase (ERK) 1/2 but selectively inhibited PDGF-BB–mediated ERK1/2 nuclear translocation.

Conclusions— Our data suggest that apoD selectively modulates the proliferative response of VSMC to growth factors by a mechanism related to nuclear translocation of ERK1/2.

Key Words: apolipoprotein D • vascular smooth muscle cells • platelet-derived growth factor-BB • fibroblast growth factor-2 • extracellular signal–regulated kinase phosphorylation and nuclear translocation • proliferation

This article has been cited by other articles:

				Y.-W. Chen, C. M. Gregory, M. T. Scarborough, R. Shi, G. A. Walter, and K. Vandenborne Transcriptional pathways associated with skeletal muscle disuse atrophy in humans Physiol Genomics, November 14, 2007; 31(3): 510 - 520. [Abstract] [Full Text] [PDF]

				G. Karakiulakis, E. Papakonstantinou, A. J. Aletras, M. Tamm, and M. Roth Cell Type-specific Effect of Hypoxia and Platelet-derived Growth Factor-BB on Extracellular Matrix Turnover and Its Consequences for Lung Remodeling J. Biol. Chem., January 12, 2007; 282(2): 908 - 915. [Abstract] [Full Text] [PDF]

				A. Lawrie, E. Spiekerkoetter, E. C. Martinez, N. Ambartsumian, W. J. Sheward, M. R. MacLean, A. J. Harmar, A.-M. Schmidt, E. Lukanidin, and M. Rabinovitch Interdependent Serotonin Transporter and Receptor Pathways Regulate S100A4/Mts1, a Gene Associated With Pulmonary Vascular Disease Circ. Res., August 5, 2005; 97(3): 227 - 235. [Abstract] [Full Text] [PDF]

				Y. Liu, Y. J. Suzuki, R. M. Day, and B. L. Fanburg Rho Kinase-Induced Nuclear Translocation of ERK1/ERK2 in Smooth Muscle Cell Mitogenesis Caused by Serotonin Circ. Res., September 17, 2004; 95(6): 579 - 586. [Abstract] [Full Text] [PDF]

				W. C.Y. Leung, A. Lawrie, S. Demaries, H. Massaeli, A. Burry, S. Yablonsky, J. M. Sarjeant, E. Fera, E. Rassart, J. G. Pickering, et al. Apolipoprotein D and Platelet-Derived Growth Factor-BB Synergism Mediates Vascular Smooth Muscle Cell Migration Circ. Res., July 23, 2004; 95(2): 179 - 186. [Abstract] [Full Text] [PDF]